We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)


Focused on second-line NSCLC and AML

Update | 12 February 2020

Mereo BioPharma

Funding deals worth up to $33m announced

Lighthouse | 11 February 2020


US IND for SCIB1 gives Phase II study the green light

Lighthouse | 03 February 2020


Interim results show encouraging progress

Update | 31 January 2020

Hutchison China MediTech

2020 set to be the “breakthrough” year

Update | 27 January 2020

Hutchison China MediTech

$110m raised through ADS public offer

Lighthouse | 23 January 2020

Hutchison China MediTech

SANET-p trial stopped early for efficacy

Lighthouse | 21 January 2020

Futura Medical

Fund raise of £3.25m, at 8p a share, confirmed at EGM

Lighthouse | 21 January 2020


Third collaboration for AvidiMab platform

Lighthouse | 20 January 2020


Increasingly in demand as partner of choice

Update | 20 January 2020
322 results found.